NCT02904369View on ClinicalTrials.gov

PK and PD Study of Oral F/TAF for HIV Prevention

PHASE1CompletedINTERVENTIONAL

Enrollment

73

Participants

Timeline

Start Date

October 6, 2016

Primary Completion Date

November 21, 2017

Study Completion Date

November 21, 2017

Conditions

HIV

Interventions

DRUG

Emtricitabine

DRUG

Tenofovir alafenamide

DRUG

Tenofovir disoproxil

Trial Locations (3)

15213

Magee-Womens Research Institute and Foundation, Pittsburgh

23507

Eastern Virginia Medical School Clinical Research Center, Norfolk

Unknown

Profamilia, Santo Domingo

Sponsors

Collaborators (1)

Agility Clinical, Inc.

All Listed Sponsors

collaborator

United States Agency for International Development (USAID)

FED

collaborator

Agility Clinical, Inc.

INDUSTRY

lead

CONRAD

OTHER